Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.

Mayo Clinic proceedings·2017
Same author

Report of the 2012-2013 standing committee on advocacy: advocacy tools and resources: a framework for increasing member engagement.

American journal of pharmaceutical education·2013
Same author

Report of the 2011-2012 Academic Affairs Standing Committee: the evolving role of scholarly teaching in teaching excellence for current and future faculty.

American journal of pharmaceutical education·2012
Same author

Treatments for methamphetamine abuse: a literature review for the clinician.

Journal of pharmacy practice·2011
Same author

Report of the AACP Special Committee on Substance Abuse and Pharmacy Education.

American journal of pharmaceutical education·2011
Same author

Ambition and vision at student awards.

Health estate·2010

Related Experiment Video

Updated: Jul 5, 2026

Microdialysis of Ethanol During Operant Ethanol Self-administration and Ethanol Determination by Gas Chromatography
10:11

Microdialysis of Ethanol During Operant Ethanol Self-administration and Ethanol Determination by Gas Chromatography

Published on: September 5, 2012

Ethylglucuronide as a biomarker for ethanol detection.

Julie C Kissack1, Jaime Bishop, Amber Leatherwood Roper

  • 1College of Pharmacy, Harding University, Searcy, Arkansas 72149-2230, USA.

Pharmacotherapy
|May 28, 2008
PubMed
Summary

Ethylglucuronide (EtG) is a reliable biomarker for detecting ethanol intake for up to 80 hours. However, clinicians must consider potential false positives from incidental exposure and false negatives from UTIs when interpreting EtG test results.

More Related Videos

Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography
08:22

Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography

Published on: February 11, 2020

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
12:02

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis

Published on: April 11, 2016

Related Experiment Videos

Last Updated: Jul 5, 2026

Microdialysis of Ethanol During Operant Ethanol Self-administration and Ethanol Determination by Gas Chromatography
10:11

Microdialysis of Ethanol During Operant Ethanol Self-administration and Ethanol Determination by Gas Chromatography

Published on: September 5, 2012

Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography
08:22

Quantification of Ethanol Levels in Zebrafish Embryos Using Head Space Gas Chromatography

Published on: February 11, 2020

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
12:02

Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis

Published on: April 11, 2016

Area of Science:

  • Clinical Chemistry
  • Toxicology
  • Biomarkers

Background:

  • Ethanol intake assessment relies on various biomarkers.
  • Ethylglucuronide (EtG) is a minor ethanol metabolite with a prolonged detection window.

Purpose of the Study:

  • To evaluate the clinical utility of ethylglucuronide as a biomarker for ethanol consumption.
  • To review the strengths and limitations of EtG testing in clinical practice.

Main Methods:

  • A MEDLINE search of English-language literature (1987-2007) for ethylglucuronide.
  • Review of clinical trials, case reports, non-medical media, and government documents.

Main Results:

  • Ethylglucuronide can be detected in urine within 1 hour of ethanol ingestion, persisting up to 80 hours.
  • Potential for false-positive results due to incidental ethanol exposure.
  • Risk of false-negative results in cases of urinary tract infections caused by specific bacteria.

Conclusions:

  • Ethylglucuronide offers an extended detection window compared to other biomarkers.
  • Accurate interpretation requires a comprehensive drug history and consideration of potential confounding factors.
  • Confirmation with quantification and self-report is recommended for positive screen results to avoid misinterpretation and adverse consequences.